Similar anti-neuroinflammatory effects were detected in a systemic LPS exposure model leading to AD-like phenotypes in the CNS (58), although additional studies clarifying the role of CTSB in neuroinflammation in established AD models are needed. The gene discussed is CTSB; the disease is Alzheimer disease.